4.7 Review

Advanced drug delivery systems and artificial skin grafts for skin wound healing

期刊

ADVANCED DRUG DELIVERY REVIEWS
卷 146, 期 -, 页码 209-239

出版社

ELSEVIER
DOI: 10.1016/j.addr.2018.12.014

关键词

Wound healing; Scaffold; Skin substitute

资金

  1. NIH [AR073935, HL140275]
  2. Global Research Laboratory Program (Korean NRF) [2015032163]
  3. Global Research Development Center Program (Korean NRF) [2018K1A4A3A01064257]
  4. Basic Science Research Program (Korean NRF) [2016R1A6A3A03012178]
  5. National Key R&D Program of China [2018YFC1105704, 2017YFC1103304, 2016YFA0101000, 2016YFA0101002]
  6. NSFC [81871569, 81101883, 81721092, 81372067, 81230041, 81121004, 81421064]
  7. National Basic Science and Development Program (973 Program) [2012CB518105]
  8. National Research Foundation of Korea [2016R1A6A3A03012178] Funding Source: Korea Institute of Science & Technology Information (KISTI), National Science & Technology Information Service (NTIS)

向作者/读者索取更多资源

Cutaneous injuries, especially chronic wounds, burns, and skin wound infection, require painstakingly long-term treatment with an immense financial burden to healthcare systems worldwide. However, clinical management of chronic wounds remains unsatisfactory in many cases. Various strategies including growth factor and gene delivery as well as cell therapy have been used to enhance the healing of non-healing wounds. Drug delivery systems across the nano, micro, and macroscales can extend half-life, improve bioavailability, optimize pharmacokinetics, and decrease dosing frequency of drugs and genes. Replacement of the damaged skin tissue with substitutes comprising cell-laden scaffold can also restore the barrier and regulatory functions of skin at the wound site. This review covers comprehensively the advanced treatment strategies to improve the quality of wound healing. (C) 2018 Published by Elsevier B.V.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据